INTS- due for a big surge

Alright fellas, INTS surged from .30 to 1.75 about 3 months ago on groundbreaking phase 1/2 data on their tumor treatment with direct injection. Since then they have bled all the way back down to .39 because day traders have no patience and shorts. They are expected to start phase 3 enrollment this month or next. The drugs they use in the injection have been FDA approved for decades now and are extremely effective in treating cancer, but are extremely harsh on the rest of the body when used in chemo. Their novel injection treatment shows great effectiveness, causes the abscopal effect on other tumors that aren’t treated, and drastically lengthened the life expectancy of stage 4 terminal candidates. In terms of “safest” high risk/reward plays, I can’t find a better one than this one at these levels. They filed AND received a patent for their novel treatment and have multiple phase 2 studies in their pipeline. Their market cap is $20 million currently and this is a no brainer $200+ mil company that will either get joint ventures or straight up bought, just my opinion obviously. They have funding until 2027 but will most likely raise more funding for phase 3 trials starting soon. Once you reach phase 3 though, big money and corporations starts to get way more interested. Good luck out there gents. I can link articles for any questions on the validity of this if you’d like.